Skip to content

UNITED THERAPEUTICS Corp

UTHR

CIK 0001082554

← back to feed
Revenue (TTM)
$3.17B
+10.6% YoY Q1 Apr 2026
Net Income (TTM)
$1.25B
+11.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
$26.02
+13.1% YoY Q1 Apr 2026
Gross Margin
86.9%
Q1 Apr 2026
Operating Margin
46.0%
Q1 Apr 2026
Net Margin
39.2%
Q1 Apr 2026
Free Cash Flow (TTM)
$1.42B
Q1 Apr 2026
Cash
$1.28B
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
42.45M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings